CONCLUSION: Our study provides further evidence for a possible pathophysiological role of Na(V)1.7 in anxiety and dysautonomia. Combined with off-target effects on Na(V) channel function, daily administration of 1 mg short-acting guanfacine may be sufficient to normalize Na(V) channel mutation-induced changes in sympathetic activity, perhaps aided by partial inhibition of Na(V)1.7 or other channel subtypes. In a broader context, expanding genetic and functional data about ion channel aberrations…
